The approval has been confirmed for the UK, Belgium, Finland, Ireland, Luxemburg, Netherlands and Sweden. Octapharma’s manufacturing process for OctaplasLG, which is a solvent/detergent treated, prion-reduced, plasma product
The study conducted by Scott Forbes from University of Alberta is named "The acute effects of a low and high dose of oral L-arginine supplementation in young, active
The drug received orphan drug status by the European Medicines Agency (EMA) in December 2008. SMT C1100 is a small molecule drug that increases (upregulating) production of a
SOHM president and CEO Shailesh Shah said they have completed the previously announced acquisition of the tangible and intangible assets, rights and technical intellectual property and formulation of
Spectrum said with the approval of removing bioscan, patients undergoing treatment with Zevalin will now receive two infusions of rituximab, followed by a 10-minute injection of Zevalin (RRZ).
According to the company, the proceeds from the financing will be used to fund the continued clinical development of PB-272 (oral neratinib). PB-272 (oral neratinib) is an irreversible
The multidisciplinary team includes researchers from the Virginia Commonwealth University School of Medicine, together with the Mount Sinai School of Medicine in New York and the University of
The innovation fund, created in March 2008, intends to support human health research projects in Québec. The first research project is named Impact des inhibiteurs intracellulaires du DCIR
Under the collaboration deal, NCI and NHGRI will apply Horizon’s rAAV gene editing technology (GENESIS) to engineer human isogenic disease models for its researchers. In addition, X-MAN (gene
The product, whose manufacturing and packaging has been completed, will be made available through Marisol Therapeutics for patient usage. The second Cannabis Science Brand extract-based formulation contains the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.